FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Cipla LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500087 P/E (TTM) :24.72
ISIN Demat:INE059A01026 Div & Yield %:1.01 EPS (TTM) :63.95
Book Value (RS) :397.3834657 Market Cap (Rs Cr.):127687.56 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 4,495.16 3,969.86 13.23
Other Income 254.66 289.14 -11.93
PBIDT 1,777.29 1,727.18 2.90
Interest 2.65 3.00 -11.67
PBDT 1,774.64 1,724.18 2.93
Depreciation 141.30 145.71 -3.03
PBT 1,633.34 1,578.47 3.48
Tax 412.22 406.73 1.35
Deferred Tax 10.59 -6.42 0.00
PAT 1,210.53 1,178.16 2.75

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)